In episode two, we continue our conversation about AI and supervised machine learning in clinical trials with Walker Bradham, senior director of product management and design at Zelta by Merative. The discussion covers Zelta’s approach to AI, which is driven by use cases, the benefits of supervised ML for trials, and Zelta’s strategy and vision for AI. 

Hosted on Acast. See acast.com/privacy for more information.

AI and supervised machine learning have considerable benefits for clinical trials. The first episode in this GlobalData-produced series by Zelta will flesh out the use cases, with a focus on generative AI vs supervised machine learning models. The guest is Walker Bradham, senior director of product management and design at Zelta by Merative. He explains the exciting applications, but cautions about the possible pitfalls, and underlines why supervised ML has become the driver of Zelta’s AI approach. 

Hosted on Acast. See acast.com/privacy for more information.